TY - JOUR
T1 - Blood coagulation factors as inflammatory mediators
AU - Schoenmakers, Saskia H. H. F.
AU - Reitsma, Pieter H.
AU - Spek, C. Arnold
PY - 2005
Y1 - 2005
N2 - After the first observations about blood coagulation by Hippocrates, it took until the early 1900s before the classic theory of blood coagulation was presented. As more and more other coagulation factors were discovered, the four-factor coagulation scheme became more complex, but better understood, leading to the current coagulation cascade. As during the last decade it turned out that coagulation factors might do more than just promoting (or inhibiting) blood coagulation, new scientific avenues were pursued focusing on coagulation-independent properties of individual coagulation factors. This led to the current understanding that coagulation factors, like tissue factor (TF), FVII, FX, and thrombin, are important players in inflammation, vascular development, angiogenesis, and tumorigenesis. However, the molecular mechanism by which coagulation factors exert their pleiotropic effects in pathophysiology remains one of the major challenges in the field. This overview presents current insight in how the main coagulation factors might induce inflammation. (C) 2004 Elsevier Inc. All rights reserved
AB - After the first observations about blood coagulation by Hippocrates, it took until the early 1900s before the classic theory of blood coagulation was presented. As more and more other coagulation factors were discovered, the four-factor coagulation scheme became more complex, but better understood, leading to the current coagulation cascade. As during the last decade it turned out that coagulation factors might do more than just promoting (or inhibiting) blood coagulation, new scientific avenues were pursued focusing on coagulation-independent properties of individual coagulation factors. This led to the current understanding that coagulation factors, like tissue factor (TF), FVII, FX, and thrombin, are important players in inflammation, vascular development, angiogenesis, and tumorigenesis. However, the molecular mechanism by which coagulation factors exert their pleiotropic effects in pathophysiology remains one of the major challenges in the field. This overview presents current insight in how the main coagulation factors might induce inflammation. (C) 2004 Elsevier Inc. All rights reserved
U2 - https://doi.org/10.1016/j.bcmd.2004.09.001
DO - https://doi.org/10.1016/j.bcmd.2004.09.001
M3 - Article
C2 - 15607697
SN - 1079-9796
VL - 34
SP - 30
EP - 37
JO - Blood cells, molecules & diseases
JF - Blood cells, molecules & diseases
IS - 1
ER -